Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Go back to Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
(NASDAQ: ROIV) Delayed: 35.01 -0.09 (0.26%)
Previous Close $35.10    52 Week High
Open $35.23    52 Week Low
Day High $35.59    P/E N/A 
Day Low $34.80    EPS
Volume 4,043,255       

(NASDAQ: ROIV) Delayed: 35.01 -0.09 (0.26%)
Previous Close $35.10    52 Week High
Open $35.23    52 Week Low
Day High $35.59    P/E N/A 
Day Low $34.80    EPS
Volume 4,043,255